Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the skin following ultraviolet radiation

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 130-139

  Osborne Hereford, Amber V ^a   Rogers, Scott W ^a,b   Gahring, Lorise C ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytokine; Inflammation; Neuronal nicotinic; SOCS3; Ultraviolet radiation

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NICOTINE; NICOTINIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; KNOCKOUT MOUSE; MALE; MOUSE; NEUROIMMUNOLOGY; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION;

ANIMALS; CYTOKINES; FEMALE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; RECEPTORS, NICOTINIC; SKIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; ULTRAVIOLET RAYS;

EID: 37749038270     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.029     Document Type: Article

References (42)

1. Alkondon M., and Albuquerque E.X. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog. Brain Res. 145 (2004) 109-120
2. Arredondo J., Nguyen V.T., Chernyavsky A.I., Bercovich D., Orr-Urtreger A., Kummer W., Lips K., Vetter D.E., and Grando S.A. Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. J. Cell Biol. 159 (2002) 325-336
3. Arredondo J., Nguyen V.T., Chernyavsky A.I., Bercovich D., Orr-Urtreger A., Vetter D.E., and Grando S.A. Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. Life Sci. 72 (2003) 2063-2067
4. Arredondo J., Chernyavsky A.I., Marubio L.M., Beaudet A.L., Jolkovsky D.L., Pinkerton K.E., and Grando S.A. Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells. Am. J. Pathol. 166 (2005) 597-613
5. Brunzell D.H., Russell D.S., and Picciotto M.R. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J. Neurochem. 84 (2003) 1431-1441
6. Carlson N.G., Bacchi A., Rogers S.W., and Gahring L.C. Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway. J. Neurobiol. 35 (1998) 29-36
7. Chernyavsky A.I., Arredondo J., Marubio L.M., and Grando S.A. Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J. Cell Sci. 117 (2004) 5665-5679
8. Conti-Tronconi B.M., McLane K.E., Raftery M.A., Grando S.A., and Protti M.P. The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit. Rev. Biochem. Mol. Biol. 29 (1994) 69-123
9. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., and Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4 (2003) 540-545
10. Daynes R.A., Samlowski W.E., Burnham D.K., Gahring L.C., and Roberts L.K. Immunobiological consequences of acute and chronic UV exposure. Curr. Probl. Dermatol. 15 (1986) 176-194
11. de Jonge W.J., van der Zanden E.P., The F.O., Bijlsma M.F., van Westerloo D.J., Bennink R.J., Berthoud H.R., Uematsu S., Akira S., van den Wijngaard R.M., and Boeckxstaens G.E. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6 (2005) 844-851
12. Frobose H., Ronn S.G., Heding P.E., Mendoza H., Cohen P., Mandrup-Poulsen T., and Billestrup N. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20 (2006) 1587-1596
13. Fujii Y.X., Fujigaya H., Moriwaki Y., Misawa H., Kasahara T., Grando S.A., and Kawashima K. Enhanced serum antigen-specific IgG(1) and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J. Neuroimmunol. 189 (2007) 69-74
14. Gahring L.C., and Daynes R.A. Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance. J. Immunol. 136 (1986) 2868-2874
15. Gahring L.C., and Rogers S.W. Neuronal nicotinic acetylcholine receptor expression and function on non-neuronal cells. The AAPS Journal. 7 (2005) E885-E894
16. Gahring L., Baltz M., Pepys M.B., and Daynes R. Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro. Proc. Natl. Acad. Sci. U S A 81 (1984) 1198-1202
17. Gahring L.C., Meyer E.L., and Rogers S.W. Nicotine-induced neuroprotection against N-methyl-d-aspartic acid or beta-amyloid peptide occur through independent mechanisms distinguished by pro-inflammatory cytokines. J. Neurochem. 87 (2003) 1125-1136
18. Gahring L.C., Persiyanov K., Days E.L., and Rogers S.W. Age-related loss of neuronal nicotinic receptor expression in the aging mouse hippocampus corresponds with cyclooxygenase-2 and PPARgamma expression and is altered by long-term NS398 administration. J Neurobiol 62 4 (2004) 453-468
19. Grando S.A. Cholinergic control of epidermal cohesion. Exp Dermatol 15 (2006) 265-282
20. Grando S.A., Horton R.M., Pereira E.F., Diethelm-Okita B.M., George P.M., Albuquerque E.X., and Conti-Fine B.M. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J. Invest. Dermatol. 105 (1995) 774-781
21. Grando S.A., Horton R.M., Mauro T.M., Kist D.A., Lee T.X., and Dahl M.V. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J. Invest. Dermatol. 107 (1996) 412-418
22. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol. Biochem. Pharmacol. 147 (2003) 1-46
23. Huston J.M., Ochani M., Rosas-Ballina M., Liao H., Ochani K., Pavlov V.A., Gallowitsch-Puerta M., Ashok M., Czura C.J., Foxwell B., Tracey K.J., and Ulloa L. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203 (2006) 1623-1628
24. Kalayciyan A., Orawa H., Fimmel S., Perschel F.H., Gonzalez J.B., Fitzner R.G., Orfanos C.E., and Zouboulis C.C. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behcet's disease. J Invest. Dermatol. 127 (2007) 81-89
25. Kurzen H., Wessler I., Kirkpatrick C.J., Kawashima K., and Grando S.A. The non-neuronal cholinergic system of human skin. Horm. Metab. Res. 39 (2007) 125-135
26. lsen A.E., Heding P.E., Frobose H., Ronn S.G., Kruhoffer M., Orntoft T.F., Darville M., Eizirik D.L., Pociot F., Nerup J., Mandrup-Poulsen T., and Billestrup N. Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways. Diabetologia 47 (2004) 1998-2011
27. Matalka K.Z., Tutunji M.F., Abu-Baker M., and Abu Baker Y. Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines. Neuro. Endocrinol. Lett. 26 (2005) 231-236
28. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., Craig C.R., Collins A.C., Damaj M.I., Donny E.C., Gardiner P.S., Grady S.R., Heberlein U., Leonard S.S., Levin E.D., Lukas R.J., Markou A., Marks M.J., McCallum S.E., Parameswaran N., Perkins K.A., Picciotto M.R., Quik M., Rose J.E., Rothenfluh A., Schafer W.R., Stolerman I.P., Tyndale R.F., Wehner J.M., and Zirger J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190 (2007) 269-319
29. Metz C.N., and Tracey K.J. It takes nerve to dampen inflammation. Nat. Immunol. 6 (2005) 756-757
30. Misery L. Nicotine effects on skin: are they positive or negative?. Exp. Dermatol. 13 (2004) 665-670
31. Nguyen V.T., Ndoye A., Hall L.L., Zia S., Arredondo J., Chernyavsky A.I., Kist D.A., Zelickson B.D., Lawry M.A., and Grando S.A. Programmed cell death of keratinocytes culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine. J Cell. Sci. 114 (2001) 1189-1204
32. Orr-Urtreger A., Kedmi M., Rosner S., Karmeli F., and Rachmilewitz D. Increased severity of experimental colitis in alpha5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport 16 (2005) 1123-1127
33. Pavlov V.A., Wang H., Czura C.J., Friedman S.G., and Tracey K.J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9 (2003) 125-134
34. Richardson C.E., Morgan J.M., Jasani B., Green J.T., Rhodes J., Williams G.T., Lindstrom J., Wonnacott S., Peel S., and Thomas G.A. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. Qjm 96 (2003) 57-65
35. Rogers S.W., Gahring L.C., Collins A.C., and Marks M. Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration. J. Neurosci. 18 (1998) 4825-4832
36. Sauder D.N., Carter C.S., Katz S.I., and Oppenheim J.J. Epidermal cell production of thymocyte activating factor (ETAF). J. Invest. Dermatol. 79 (1982) 34-39
37. Sopori M.L., Kozak W., Savage S.M., Geng Y., and Kluger M.J. Nicotine-induced modulation of T Cell function. Implications for inflammation and infection. Adv. Exp. Med. Biol. 437 (1998) 279-289
38. Soy M., Erken E., Konca K., and Ozbek S. Smoking and Behçet's disease. Clin. Rheumatol. 19 (2000) 508-509
39. Thomas G.A., Rhodes J., and Ingram J.R. Mechanisms of disease: nicotine-a review of its actions in the context of gastrointestinal disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005) 536-544
40. Wang J., and Campbell I.L. Cytokine signaling in the brain: putting a SOCS in it?. J. Neurosci. Res. 67 (2002) 423-427
41. Wong P.K., Egan P.J., Croker B.A., O'Donnell K., Sims N.A., Drake S., Kiu H., McManus E.J., Alexander W.S., Roberts A.W., and Wicks I.P. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 116 (2006) 1571-1581
42. Zia S., Ndoye A., Nguyen V.T., and Grando S.A. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res. Commun. Mol. Pathol. Pharmacol. 97 (1997) 243-262